MedCell Bioscience Ltd., of London, and NovaThera Ltd., of Cambridge, UK, are merging. The combined entity, which will continue to trade under the MedCell Bioscience name, will have a post-merger valuation of about 30 million [pounds sterling] (US$59.8 million). NovaThera brings two platform technologies, …
Комментариев нет:
Отправить комментарий